Moolec Science (MLEC) Cash from Financing Activities (2022 - 2024)
Moolec Science (MLEC) reported Cash from Financing Activities of -$8.9 million for Q4 2024, up 62.11% on a YoY basis from -$5.5 million in Q1 2024, and down 1533.11% sequentially from -$542417.0 in Q3 2024.
Moolec Science (MLEC) Cash from Financing Activities (2022 - 2024) Analysis & Trends
Moolec Science (MLEC) has 3 years of Cash from Financing Activities data on file, last reported at -$8.9 million in Q4 2024.
- For the quarter ending Q4 2024, Cash from Financing Activities rose 62.11% year-over-year to -$8.9 million; the trailing twelve-month figure through Dec 2024 stood at -$15.6 million (down 136.49% YoY), and the FY2025 full-year result was -$15.0 million, down 906.47% from the prior year.
- Cash from Financing Activities slipped to -$8.9 million in Q4 2024, from -$542417.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $66.2 million in Q2 2023 to a low of -$23.4 million in Q4 2023.
- A 3-year average of $3.5 million and a median of -$334930.5 in 2023 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities surged 13144.74% in 2023 and tumbled 325.61% in 2024, its largest moves.
- Tracing MLEC's Cash from Financing Activities over 3 years: stood at $500000.0 in 2022, then tumbled by 4775.75% to -$23.4 million in 2023, then soared by 62.11% to -$8.9 million in 2024.
- Business Quant data shows MLEC's Cash from Financing Activities at -$8.9 million in Q4 2024, -$542417.0 in Q3 2024, and -$11.0 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 30.14 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 68.63 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 9,311.16 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -538.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -802.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 238.74 Mn |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -8.86 Mn |
| Dec 31, 2024 | -8.86 Mn |
| Sep 30, 2024 | -542,417.00 |
| Sep 30, 2024 | -542,417.00 |
| Jun 30, 2024 | -11.00 Mn |
| Jun 30, 2024 | -11.00 Mn |
| Mar 31, 2024 | 4.82 Mn |
| Mar 31, 2024 | 4.82 Mn |
| Dec 31, 2023 | -23.38 Mn |
| Dec 31, 2023 | -23.38 Mn |
| Sep 30, 2023 | -127,444.00 |
| Sep 30, 2023 | -127,444.00 |
| Jun 30, 2023 | 66.22 Mn |
| Jun 30, 2023 | 66.22 Mn |
| Jun 30, 2022 | 500,000.00 |
| Jun 30, 2022 | 500,000.00 |